Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Thorac Oncol ; 5(8): 1201-5, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20588201

RESUMEN

INTRODUCTION: In early stage non-small cell lung cancer (NSCLC), presence of lymphatic micrometastases and isolated tumor cells, primarily detected by immunohistochemistry, is suggested to be a prognostic factor. However, there is no consensus whether immunohistochemistry should be used routinely in lymph node assessment.The goal of our study was to determine whether recurrent disease is associated with the presence of lymphatic micrometastases and/or isolated tumor cells, at the time of the lung resection. METHODS: We retrospectively analyzed the prevalence of lymphatic micrometastases and/or isolated tumor cells in two groups of patients, who underwent a curative resection for early stage NSCLC. Group I had a follow-up of 5 years without recurrent disease. Group II consisted of a matched group of patients with recurrent disease. Patients were originally classified as having negative mediastinal lymph nodes.All lymph nodes obtained by mediastinoscopy and thoracotomy were re-examined by serial sectioning and immunohistochemistry. RESULTS: Micrometastases and/or isolated tumor cells were found in one of 16 patients in group I, which was significantly different from six of 16 patients in group II. (Fisher exact test, 4.6; p, 0.04; risk ratio, 2.4).Serial sectioning and immunohistochemistry did not change N-stage for the single patient in group I, in contrast to all six patients in group II. CONCLUSION: Presence of lymphatic micrometastases and/or isolated tumor cells is associated with distant recurrence in patients with early stage NSCLC. We recommend the routine use of serial sectioning and immunohistochemistry in lymph node assessment to improve the accuracy of staging.


Asunto(s)
Adenocarcinoma/secundario , Carcinoma de Células Grandes/secundario , Carcinoma de Pulmón de Células no Pequeñas/secundario , Neoplasias Pulmonares/patología , Recurrencia Local de Neoplasia/patología , Neoplasias de Células Escamosas/secundario , Adenocarcinoma/cirugía , Adulto , Anciano , Carcinoma de Células Grandes/cirugía , Carcinoma de Pulmón de Células no Pequeñas/cirugía , Femenino , Humanos , Técnicas para Inmunoenzimas , Neoplasias Pulmonares/cirugía , Metástasis Linfática , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/cirugía , Neoplasias de Células Escamosas/cirugía , Pronóstico , Estudios Retrospectivos , Tasa de Supervivencia
2.
Ann Hematol ; 83(7): 447-9, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-14689234

RESUMEN

A 55-year old man developed a hemorrhagic pneumonia, likely due to infection with Kytococcus sedentarius during neutropenia following induction chemotherapy for acute myeloid leukemia. Severe mucosal barrier injury and the selective pressure of broad-spectrum antibiotics probably made it possible for this normally harmless commensal to penetrate the gut, spread through the blood stream, and invade the lungs.


Asunto(s)
Infecciones por Actinomycetales/microbiología , Actinomycetales/aislamiento & purificación , Hemoptisis/etiología , Neumonía Bacteriana/microbiología , Sobreinfección/microbiología , Actinomycetales/patogenicidad , Infecciones por Actinomycetales/etiología , Aciclovir/efectos adversos , Aciclovir/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Bacteriemia/etiología , Bacteriemia/microbiología , Traslocación Bacteriana , Cefepima , Cefalosporinas/efectos adversos , Cefalosporinas/uso terapéutico , Infecciones por Clostridium/complicaciones , Colistina/efectos adversos , Colistina/uso terapéutico , Citarabina/administración & dosificación , Citarabina/efectos adversos , Daunorrubicina/administración & dosificación , Daunorrubicina/efectos adversos , Quimioterapia Combinada/efectos adversos , Quimioterapia Combinada/uso terapéutico , Etopósido/administración & dosificación , Etopósido/efectos adversos , Resultado Fatal , Humanos , Hidroxiurea/administración & dosificación , Hidroxiurea/efectos adversos , Huésped Inmunocomprometido , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Leucemia Mieloide Aguda/complicaciones , Leucemia Mieloide Aguda/tratamiento farmacológico , Masculino , Metronidazol/efectos adversos , Metronidazol/uso terapéutico , Persona de Mediana Edad , Neutropenia/inducido químicamente , Neutropenia/complicaciones , Neumonía Bacteriana/complicaciones , Sobreinfección/etiología , Teicoplanina/efectos adversos , Teicoplanina/uso terapéutico , Combinación Trimetoprim y Sulfametoxazol/efectos adversos , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda